Gent, Belgium
Gent, Belgium

Ghent University is a highly ranked Dutch-speaking public university located in Ghent, Belgium. It is one of the larger Flemish universities, consisting of 41,000 students and 9,000 staff members. The current rector is Anne De Paepe . As of 2014, Ghent University ranks as 90th globally according to Times Higher Education, 129th according to QS World University Rankings and 70th according to the Academic Ranking of World Universities. It is therefore considered to be a top university, globally.It was established in 1817 by King William I of the Netherlands. After the Belgian revolution of 1830, it was administered by the newly formed Belgian state. French became the academic language until 1930, when Ghent University became the first Dutch-speaking university in Belgium. In 1991, the university was granted major autonomy and changed its name from State University of Ghent to its current name. Wikipedia.


Time filter

Source Type

Patent
Ghent University and Imec | Date: 2016-11-22

A sensor for sensing a substance such as for example glucose. The sensor is implantable in the body of a living creature. The sensor has a photonic integrated circuit, e.g. silicon-photonics integrated circuit, for spectrally processing radiation interacting with the sample. A continuous monitoring system can also include such a sensor.


Patent
Vib Vzw, Ghent University, The United States Of America and Dartmouth College | Date: 2017-02-01

The present invention relates to single domain antibodies that are directed against respiratory syncytial virus (RSV). More specifically, it relates to single domain antibodies that bind to the prefusion form of the fusion (F) protein of RSV. The invention relates further to the use of these single domain antibodies for prevention and/or treatment of RSV infections, and to pharmaceutical compositions comprising these single domain antibodies.


Patent
Ghent University | Date: 2017-01-18

The present invention relates to the field of molecular pathology (for example cancer diagnosis, prognosis, treatment and/or therapy prediction) through the detection of RNA, mutations, copy number changes and determination of the methylation status of specific sequences of the genome of individual patients in hybridization assays (southern blot, ISH, dot blot) including in situ determination of the methylation status of specific sequences of the genome of individual patients in individual cells. More specifically the present invention relates to: a) target-specific probes covalently-attached to a labeled tail, b) the synthesis method of said probe, c) the usage of said probe such as an in situ hybridization-based method to correlate the methylation status of a promoter region of a gene in a biopsy or cytology specimen of a patient to the morphology and localization in that specimen, and d) kits comprising said target-specific probes. The latter method and products allow detection of (epi) genetic changes in specific cell types of histological or cytological (cancer) specimens or on membranes which will contribute to scientific research and which will help physicians to accurately diagnose diseases and/or start an appropriate treatment.


Patent
Ghent University and Allnex Belgium S.A. | Date: 2017-01-11

The invention pertains to the technical field of urethane based materials, in particular to radiation curable urethane precursors that are cross-linkable in solid form and materials obtainable therefrom. In addition the invention pertains to methods for manufacturing these precursors and materials, and their uses. The invention is advantageous to the fields of i.e. coatings and biomedical applications.


Patent
Koninklijke KPN N.V., Iminds and Ghent University | Date: 2017-01-25

A method of provisioning a service in a communication network is described, in which the service comprises at least one virtual network function and at least one virtual network path, which at least one virtual network function and at least one virtual network path are to be implemented in the communication network. The method comprises:- obtaining (202) affinity constraints and/or anti-affinity constraints relating to mapping the at least one virtual network path onto the communication network,- optionally obtaining (202) affinity constraints and/or anti-affinity constraints relating to mapping the at least one virtual network function onto the communication network, and- mapping (203) the at least one virtual network function and at least one virtual network path onto the communication network subject to said constraints.


Patent
Ghent University and Vib Vzw | Date: 2015-03-30

The disclosure provides compositions and methods comprising a sialoadhesin binding moiety for treating metabolic and genetic bone disease, especially for treating a bone disorder of hyper-resorption of bone and/or enhanced activation of osteoclasts.


Patent
Ghent University and Iminds Vzw | Date: 2015-03-30

A computer-implemented method comprises obtaining an intermediate computer code object including a set of instructions corresponding to a task to be performed. The intermediate computer code objectbeing machine independentfurther includes for each of the at least one set of instructions one or more metadata descriptors representative of at least a complexity measure of the task to be performed. The method also comprises executing the intermediate computer code object on a computing platform comprising at least two different execution units having a different memory with a different memory location. This executing comprises selecting for each of the at least one set of instructions a target execution unit from the plurality of execution units. This selecting takes the one or more metadata descriptors and a decision rule into account, wherein the decision rule relates the plurality of complexity measures to a performance characteristic of the plurality of execution units.


Patent
Ghent University | Date: 2017-05-17

The present invention relates to hamamelitannin analogues, pharmaceutical compositions comprising the same, and combinations thereof with anti-microbial agents such as antibiotics or disinfectants. It in particular relates to the use of the compounds, compositions and combinations according to this invention in human or veterinary medicine, more in particular for use in the prevention and/or treatment of bacterial infections, such as Staphylococcus aureus infections, in humans or animals.


Patent
Ghent University and Imec | Date: 2017-05-17

A photonic integrated circuit (10) comprises an input interface (12) adapted for receiving an optical input signal and splitting it into two distinct polarization modes and furthermore adapted for rotating the polarization of one of the modes for providing the splitted signals in a common polarization mode,. The PIC also comprises a combiner (16) adapted for combining the first mode signal and the second mode signal into a combined signal and a decohering means (15) adapted for transforming at least one of the first mode signal and the second mode signal such that the first mode signal and the second mode signal are received by the combiner in a mutually incoherent state. A processing component (17) for receiving and processing said combined signal is also comprised.


Patent
Vib Vzw and Ghent University | Date: 2017-05-17

The present invention relates to plants having a decreased expression of the KIX8 and KIX9 genes which result in an increased yield, particularly an increased leaf biomass. The invention provides plants and chimeric genes which can be used to decrease the combined KIX8/KIX9 gene expression.

Loading Ghent University collaborators
Loading Ghent University collaborators